Ophthalmology meets engineering

Many perspectives.
One clearer view.

Founded in 2014, InnSight brings clinical experience and technical research together around tear fluid diagnostics.

Meet the leadership
Contextual photograph of a scientist working at a microscope
Co-founders Leanne Labriola and Dipanjan Pan connect ophthalmology with engineering
The founding idea

Answers in
a teardrop.

Co-founders Leanne Labriola and Dipanjan Pan connect ophthalmology with engineering. The company’s work aims to move tear biomarker research toward practical diagnostic tools.

Read the official company story
Leadership

A team with
complementary vision.

The current company leadership combines ophthalmology, technology and business development.

01

Leanne Labriola, DO, MBA

Chief Executive Officer

02

Dipanjan Pan, PhD

Chief Technical Officer

03

Veena Raiji, MD

Chief Medical Officer

04

Joseph Scott

Chief Business Officer

View the full official team
The Richard King Mellon Foundation announced a $515,000 social-impact investment in July 2026 following InnSight’s first-place pitch competition result
Company milestone

An idea with
growing support.

The Richard King Mellon Foundation announced a $515,000 social-impact investment in July 2026 following InnSight’s first-place pitch competition result. This is a development milestone, not evidence of regulatory clearance.

Read the foundation investment announcement

A shared view
of what comes next.

Connect with the company about research and collaboration.

Start a conversation